COVID-19: Physician Update

Updated 5-18-2020

Notify MFM: 225-924-8924 for all cases with pregnant patients who have a diagnosis or a high suspicion of COVID-19.


COVID-19 Testing

Woman’s Hospital Orders

Effective May 18, COVID-19 testing for symptomatic patients and retesting of positive patients will be performed at the Woman’s Hospital campus behind the Assessment Center.

  • Dates: Monday- Friday:  8:30 AM – 10:30 AM; by appointment only
  • Contact: Woman’s Lab at 225-924-8283 for assistance.
  • To refer a patient:
  • 1. Enter patient order electronically through EMR or fax to 225-928-8859.
    (Patient contact information must be on the order.)
  • 2. WOMAN'S SCHEDULING WILL CALL YOUR PATIENT FOR AN APPOINTMENT TIME.
  • 3. Results will be sent to physicians to communicate to patients.

Community Testing Site Orders

The community testing site has transitioned to using the OPH State Lab. Orders must be submitted using the LDH website. View full details »

Woman’s Lab Now Processing COVID-19 Tests

Woman’s is processing all inpatient and outpatient COVID-19 tests in its own lab. This required the completion of an Emergency Use Authorization (EUA) from the FDA. The Woman’s lab completed its FDA EUA for the Luminex Aries RT-PCR test in just a day and a half. Learn More »


RECOMMENDATION of Work Group for management of labor in patients with known previous or active COVID-19 infection

According to the CDC, transmission-based precautions for patients with known or suspected COVID19 may be discontinued when the following criteria are met:

    javascript:void(0);
  • at least 3 days (72 hours) have passed since recovery defined as resolution of fever without the use of fever-reducing medications and improvement in respiratory symptoms and, 
  • at least 7 days have passed since symptoms first appeared

Beginning Thursday (4/16) morning at 0700, we will begin a secondary screening for patients who have previously tested positive or have a COVID-19 test pending. The responses to these screening questions will guide patient placement decisions. Learn more… Secondary screening for previous +COVID test prior to delivery [pdf] »


Other Topics of Interest to Providers:

Masks Usage Guidelines: All healthcare/hospital employees must wear a mask while inside the facility. The mask should be worn in patient care areas, onstage and offstage common areas, elevators, and conference rooms. N95 and surgical masks should be reserved for direct patient care activities. Cloth masks should be used by administrative and support staff. View updated Woman’s Hospital Mask Usage Guidelines [PDF] »

Fit Testing: To preserve the supply of N95s, providers who are not yet fit tested will go through fit testing only if needed to provide patient care in an area with risk of exposure within the next week. Please contact Medical Staff Services (225-924-8681) to coordinate fit testing with Employee Health.

Resources:

Managed Care COVID-19 Policies

Pediatrician COVID-19 Recommendations (Word Doc) »

Summary of AJOG recommendations for COVID19 L&D processes (Word Doc) »

Updated Community Testing Site Instructions [PDF] »

ACOG: Outpatient Assessment and Mgmt for Pregnant Women With  Suspected/Confirmed COVID-19 Algorithm [PDF] »

Mother Baby Contact Guidelines [PDF] »

PPE training [video] »

CDC Information for Healthcare Providers: COVID-19 and Pregnant Women »

ACOG: Outpatient Assessment & Mgmt for Pregnant Women With Suspected/Confirmed COVID-19

Please notify MFM (225-924-8924) for all cases with pregnant patients who have a diagnosis or a high suspicion of COVID-19. Please refer to the algorithm PDF »

  • Per IMCC, admission criteria for respiratory illness patients include:
  • Hypoxemia as defined as O2 saturations less than 95% for pregnant patients
  • Respiratory rates greater than or equal to 24
  • Combined tachypnea/tachycardia with a heart rate greater than 110
  • Inpatient who have hypoxemia, a chest x-ray and ABG are recommended.
  • Other considerations:
    • Patient is with underlying combined cardio/pulmonary conditions are at higher risk for decomposition.
    • Markers of severe disease include lymphopenia, anion gap acidosis, and elevated CRP

Woman’s COVID-19 screening process

  • Screening at four access points (main entrance, Assessment Center, Physician Office Building, Cancer Pavilion).
  • Patients who screen positive will be provided a mask to wear while in the facility.
  • Support persons who screen positive will not be provided access to the facility.
  • Woman’s staff has strict instructions for self-monitoring which they are required to adhere to.
  • Physicians should also self-monitor.  Do not enter the facility if you have fever, shortness of breath, or cough.

Managing Patients with known/presumed COVID-19 infection

  • Surgical face mask placed on patient when entering the facility.
  • Patient wears a face mask at all times while moving within the facility, except when inside their patient care room.
  • Patient care rooms housing these patients will be marked with signage:  AIRBORNE PRECAUTIONS.
  • Staff entering room to care for patients will wear full PPE.  If you aren’t familiar with the process to put on and take off PPE, just ask the staff to guide you.

Telehealth

Woman’s has telehealth options that can support MD-patient communication.  Contact Paul Kirk, VP for Information Systems, for further assistance:  paul.kirk@womans.org

Telehealth Information »

Mental Health Resources

Visitor Policy Changes

Visitor Policy Update: For the protection of our patients and caregivers, Woman’s is not allowing visitors for patients who test positive or who are under investigation for COVID-19.

Click here for more details on screening and policy at updates for patients and visitors at Woman’s Hospital.